Cyanocabolamin is vitamin B-12 and is added to Semaglutide to boost energy and metabolism
After two years of trials, involving more than 400 adults with OPS, researchers have published the abstract of their findings in the New England Journal of Medicine
Interestingly, patients receiving semaglutide QW were more likely to be part of the commercial claim subgroup versus the Medicare claim subgroup, which suggests that the major differences in baseline characteristics observed were primarily driven by the commercial/Medicare ratio
Drugs with three targets are also in the pipeline, including retatrutide, Lillys triple GLP-1, GIP and glucagon agonist combination
However, increasing evidence suggests they also significantly impact neurophysiology, cognitive function, and oxidative balance